<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03418207</url>
  </required_header>
  <id_info>
    <org_study_id>SubeiPHJP</org_study_id>
    <nct_id>NCT03418207</nct_id>
  </id_info>
  <brief_title>The Accuracy of Modified TTMB in the Spatial Distribution of Prostate Cancer</brief_title>
  <official_title>The Study on the Spatial Distribution of Prostate Cancer by Modified Trans-perineal Template-guided Mapping Biopsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Subei People's Hospital of Jiangsu Province</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Subei People's Hospital of Jiangsu Province</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators plan to use modified TTMB technology to puncture prostate of participants
      suspected prostate cancer, especially those with the first negative biopsy , but having a
      rising PSA.Then, Investigators will simulate the spatial distribution of prostate cancer in
      patients with positive biopsy before radical prostatectomy by way of the TPS software system
      . And after the radical prostatectomy ,Investigators will simulate the spatial distribution
      with the help of large tissue slice technique to compare with preoperative simulation ,which
      to verify the two simulations are consistent.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators mainly plan to determine the accuracy of the modified TTMB technology in
      combination with the TPS system on the location of the tumor space distribution by comparing
      the two simulation, which is significant for the accurate focal thearpy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the spatial distribution based on the biopsy tissue</measure>
    <time_frame>2 years</time_frame>
    <description>to simulate the spatial distribution of cancer based on the biopsy tissue contained cancer with the help of TPS system</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the spatial distribution based on the large tissue slice technique</measure>
    <time_frame>2 years</time_frame>
    <description>to simulate the spatial distribution based on the large tissue slice technique after radical prostatectomy</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>TTMB for patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>give trans-perineal template-guided mapping biopsy for participants suspected prostate cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>trans-perineal template-guided mapping biopsy</intervention_name>
    <description>new super saturation of prostate biopsy technique</description>
    <arm_group_label>TTMB for patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1.Male patients;

        2.18 yrs and older, and 90 yrs and younger;

        3.Rectal examination reveal prostate nodules;

        4.B ultrasound, CT or MRI find abnormal images;

        5.PSA&gt;4ng/ml, abnormal f/t ratio and PSAD

        Exclusion Criteria:

          1. Abnormal coagulation function;

          2. Severe urinary tract infection;

          3. Serious cardiovascular and cerebrovascular disease
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xuefei Ding, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Subei People's Hospital of Jiangsu Province</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xuefei Ding, MD</last_name>
    <phone>18051061234</phone>
    <email>xuefeid@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Subei People's Hospital of Jiangsu province</name>
      <address>
        <city>Yangzhou</city>
        <state>Jiangsu</state>
        <zip>225001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xuefei Ding, MD</last_name>
      <phone>18051061234</phone>
      <email>xuefeid@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Tran M, Thompson J, BÃ¶hm M, Pulbrook M, Moses D, Shnier R, Brenner P, Delprado W, Haynes AM, Savdie R, Stricker PD. Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy. BJU Int. 2016 Jan;117(1):48-54. doi: 10.1111/bju.13090. Epub 2015 May 11.</citation>
    <PMID>25682968</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2018</study_first_submitted>
  <study_first_submitted_qc>January 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 1, 2018</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Subei People's Hospital of Jiangsu Province</investigator_affiliation>
    <investigator_full_name>Xuefei Ding,MD</investigator_full_name>
    <investigator_title>Chief physician of urology</investigator_title>
  </responsible_party>
  <keyword>TPS system</keyword>
  <keyword>trans-perineal template-guided mapping biopsy</keyword>
  <keyword>prostate cancer</keyword>
  <keyword>spatial distribution</keyword>
  <keyword>large tissue slice</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

